welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Hanns Lochmuller, PhD

Professor of Experimental Myology
University Medical Center Freiburg
University of Freiburg
Main Clinical Campus
Hugstetter Straße 55
Freiburg, Germany

Dr. Hanns currently works as a Professor of Experimental Myology at the Department of Neuropediatrics and Muscle Disorders at University Medical Center Freiburg. He was appointed the chair of experimental myology in the neuromuscular research group at the Institute of Genetic Medicine of Newcastle University in 2007-2017.

Dr. Hanns is a former chair of the Interdisciplinary Scientific Committee of the International Rare Diseases Research Consortium (IRDiRC) and former chair of the Executive Committee of the TREAT-NMD Alliance. He is co-founder and former coordinator of the German muscular dystrophy network (MD-NET), and former scientific coordinator of EuroBioBank, a European network of biobanks for rare disorders.

Hanns has a longstanding interest in the molecular genetics of the inherited myopathies and neuromuscular junction disorders, and is interested in the further study of animal models of these disorders as a means to understand their pathophysiology as well as to develop means to monitor disease progression and therapeutic interventions. Ongoing work in these areas in cell and animal models of muscular dystrophy is concentrating on gene transfer, pharmacological interventions and cell therapy.


Representative Publications:

Mass spectrometry-based protein analysis to unravel the tissue pathophysiology in Duchenne muscular dystrophy

Impact of three decades of improvements in standards of care on clinical outcomes in Duchenne muscular dystrophy

Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies

Fibronectin is a serum biomarker for Duchenne muscular dystrophy

Predictors of Health-Related Quality of Life in boys with Duchenne muscular dystrophy from six European countries